2016 annual financial data
Revelation Biosciences 2016 Operating margin
Direct answer
Operating margin was 38.43%.
Operating income was 18,759,000 USD and net income was 8,777,000 USD.
Operating cash flow was 11,599,000 USD.
Get free Revelation Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 48,812,000 USD
- Operating income
- 18,759,000 USD
- Net income
- 8,777,000 USD
- Operating cash flow
- 11,599,000 USD